المؤلفون: M Bellesso, J Pereira, L Bassolli, ANR Abdo, WFS Junior, RD Velasques, AAGS Brandão, LAPC Lage, FVR Maciel, V Rocha, H Visnadi

المصدر: Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S97- (2021)

مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2531137921003126; https://doaj.org/toc/2531-1379

URL الوصول: https://doaj.org/article/2cf920db95a34cff9acc8ebde0464143

المؤلفون: APS Ferreira, FS Seguro, ARN Abdo, FM Santos, FVR Maciel, L Nardinelli, RR Giorgi, ARL Ruiz, VG Rocha, I Bendit

المصدر: Hematology, Transfusion and Cell Therapy. 44:S214

مصطلحات موضوعية: Immunology and Allergy, Hematology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e571797e44464cbc2a80349424a73aac
https://doi.org/10.1016/j.htct.2022.09.361

المؤلفون: Ferreira APS; Hematologica Clinic Oncoclinicas, Belo Horizonte, Brazil.; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil., Seguro FS; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil.; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil., Abdo ARN; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil., Santos FM; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil., Maciel FVR; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil.; Hemato‑Oncologia, DASA-Genômica, Sao Paulo, Brazil., Nardinelli L; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco‑Immuno‑Hematology (LIM/31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil., Giorgi RR; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco‑Immuno‑Hematology (LIM/31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil., Ruiz ARL; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil., Ferreira MPS; Minas Gerais Federal University, Belo Horizonte, Brazil., Rego EM; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil.; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco‑Immuno‑Hematology (LIM/31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil., Rocha V; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil.; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco‑Immuno‑Hematology (LIM/31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil., Bendit I; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil. isbendit@usp.br.; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco‑Immuno‑Hematology (LIM/31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil. isbendit@usp.br.; Hemato‑Oncologia, DASA-Genômica, Sao Paulo, Brazil. isbendit@usp.br.

المصدر: Annals of hematology [Ann Hematol] 2023 Jul; Vol. 102 (7), pp. 1969.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Ferreira APS; Hematology Clinic Oncoclinicas, Sao Paulo, Brazil.; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil., Seguro FS; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil.; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil., Abdo ARN; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil., Santos FM; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil., Maciel FVR; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil.; Hemato-Oncologia, DASA-Genômica, Sao Paulo, Brazil., Nardinelli L; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco-Immuno-Hematology (LIM/31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil., Giorgi RR; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco-Immuno-Hematology (LIM/31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil., Ruiz ARL; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil., Ferreira MPS; Minas Gerais Federal University, Belo Horizonte, Brazil., Rego EM; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil.; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco-Immuno-Hematology (LIM/31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil., Rocha V; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil.; Department of Hematology, Cancer Institute of Sao Paulo, University of Sao Paulo Medical School (ICESP), Sao Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco-Immuno-Hematology (LIM/31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil., Bendit I; Department of Hematology, Transfusion and Cell Therapy, University of Sao Paulo Medical School (HCFMUSP), Sao Paulo, Brazil. isbendit@usp.br.; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco-Immuno-Hematology (LIM/31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil. isbendit@usp.br.; Hemato-Oncologia, DASA-Genômica, Sao Paulo, Brazil. isbendit@usp.br.

المصدر: Annals of hematology [Ann Hematol] 2023 Jul; Vol. 102 (7), pp. 1761-1771. Date of Electronic Publication: 2023 Apr 13.

نوع المنشور: Observational Study; Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy , Antineoplastic Agents*/therapeutic use, Humans ; Imatinib Mesylate/therapeutic use ; Retrospective Studies ; Prospective Studies ; Treatment Outcome ; Protein Kinase Inhibitors/therapeutic use ; Philadelphia Chromosome ; Fusion Proteins, bcr-abl/genetics

المؤلفون: Santos FM; Instituto do Cancer do Estado de Sao Paulo (ICESP), Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil., Ghelfond G; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil., Seguro FS; Instituto do Cancer do Estado de Sao Paulo (ICESP), Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil., Abdo ANR; Instituto do Cancer do Estado de Sao Paulo (ICESP), Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil., Dalessandro T; Instituto do Cancer do Estado de Sao Paulo (ICESP), Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil., Maciel FVR; Instituto do Cancer do Estado de Sao Paulo (ICESP), Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil., Bassolli L; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil., Rocha V; Instituto do Cancer do Estado de Sao Paulo (ICESP), Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.; Churchill Hospital, Oxford University, Oxford, UK., Bendit I; Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo (USP), Sao Paulo, Sao Paulo, Brazil.

المصدر: American journal of hematology [Am J Hematol] 2022 Feb 01; Vol. 97 (2), pp. E72-E74. Date of Electronic Publication: 2021 Nov 30.

نوع المنشور: Letter

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*complications , Pregnancy Complications, Neoplastic/*etiology, Adult ; Antineoplastic Agents/therapeutic use ; Female ; Humans ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy ; Pregnancy ; Pregnancy Complications, Neoplastic/drug therapy ; Pregnancy Outcome ; Protein Kinase Inhibitors/therapeutic use ; Retrospective Studies ; Young Adult

المؤلفون: Seguro FS; Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil; Instituto do Câncer do Estado de São Paulo, Sao Paulo, SP, Brazil. Electronic address: fernanda.seguro@hc.fm.usp.br., Maciel FVR; Instituto do Câncer do Estado de São Paulo, Sao Paulo, SP, Brazil., Santos FM; Instituto do Câncer do Estado de São Paulo, Sao Paulo, SP, Brazil., Abdo ANR; Instituto do Câncer do Estado de São Paulo, Sao Paulo, SP, Brazil., Pereira TDM; Instituto do Câncer do Estado de São Paulo, Sao Paulo, SP, Brazil., Nardinelli L; Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil., Rocha V; Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil., Bendit I; Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.

المصدر: Leukemia research [Leuk Res] 2021 Feb; Vol. 101, pp. 106516. Date of Electronic Publication: 2021 Jan 21.

نوع المنشور: Clinical Trial; Journal Article

بيانات الدورية: Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5835 (Electronic) Linking ISSN: 01452126 NLM ISO Abbreviation: Leuk Res Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/blood , Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy, Imatinib Mesylate/*administration & dosage , Killer Cells, Natural/*metabolism, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Imatinib Mesylate/adverse effects ; Lymphocyte Count ; Male ; Middle Aged ; Pilot Projects ; Prospective Studies ; Recurrence ; Time Factors